Showing results (121-130 of 197) with videos related to

Sort By:
Pageof 20
Plos One|August 31, 2013
Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesotheliomaFilip Mundt, Gustav Nilsonne, Sertaç Arslan, et al.
Health and Quality of Life Outcomes|October 5, 2013
Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study designRohit Lal, Nawel Bourayou, Gunnar Hillerdal, et al.
Oncotarget|January 27, 2018
Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesotheliomaMarieke Hylebos, Guy Van Camp, Geert Vandeweyer, et al.
International Journal of Molecular Sciences|August 29, 2019
Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint ExpressionElly Marcq, Jonas Rm Van Audenaerde, Jorrit De Waele, et al.
Oncotarget|November 16, 2017
<i>Ex vivo</i> evaluation of tumor cell specific drug responses in malignant pleural effusionsCarl-Olof Hillerdal, Rita Ötvös, Tünde Szatmári, et al.
Translational Lung Cancer Research|August 2, 2019
A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trialRobert A Belderbos, Paul Baas, Rossana Berardi, et al.
Oncotarget|December 7, 2017
Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control studyKevin Lamote, Paul Brinkman, Lore Vandermeersch, et al.
Cancers|January 20, 2021
The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3Elly Marcq, Jonas R M Van Audenaerde, Jorrit De Waele, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|March 6, 2018
Quality of care and variability in lung cancer management across Belgian hospitals: a population-based study using routinely available dataFrance Vrijens, Cindy De Gendt, Leen Verleye, et al.
American Journal of Respiratory and Critical Care Medicine|January 16, 2010
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesotheliomaKevin Hollevoet, Kristiaan Nackaerts, Joël Thimpont, et al.
Pageof 20